AI for Multimodal Fusion

Overview

Multimodal fusion integrates imaging with clinical labs and genomics for richer models. It enhances prediction of outcomes and personalized treatment planning. Fusion requires harmonized data and robust modeling techniques.

Techniques

Late fusion early fusion and joint representation learning are common approaches. Attention mechanisms and graph models capture complex relationships. Data preprocessing and alignment are critical for success.

Clinical Applications

Multimodal models predict treatment response survival and molecular subtypes. They support precision oncology and complex diagnostic tasks. Prospective validation demonstrates clinical utility.

Data Governance

Secure linkage of multimodal data respects privacy and consent. Standardized ontologies and metadata improve interoperability. Transparent reporting supports reproducibility and trust.

AI for Radiogenomics

Overview

Radiogenomics uses AI to correlate imaging features with molecular and genomic data. It aims to non invasively predict tumor biology and guide targeted therapy. Integration supports personalized oncology care.

Methodology

Models combine radiomic features and deep learning representations with genomic labels. Cross validation and external cohorts validate predictive associations. Interpretability links imaging markers to biological mechanisms.

Clinical Potential

Radiogenomic signatures may predict mutation status and therapy response. They reduce need for invasive sampling in some contexts. Clinical trials evaluate impact on treatment selection.

Limitations

Heterogeneity in imaging and genomic assays complicates generalization. Large multicenter datasets and harmonization are needed. Ethical use requires clear communication about predictive uncertainty.